J&J Executive
👤 Person
3
appearances
Podcast Appearances
The Journal.
The New Hit Depression Treatment? A Ketamine-Derived Nasal Spray
— And Svoboda is also the only antidepressant to ever receive breakthrough designation from the FDA, so great momentum and a long-term commitment to patients suffering with depression.
The Journal.
The New Hit Depression Treatment? A Ketamine-Derived Nasal Spray
— And Svoboda is also the only antidepressant to ever receive breakthrough designation from the FDA, so great momentum and a long-term commitment to patients suffering with depression.
The Journal.
The New Hit Depression Treatment? A Ketamine-Derived Nasal Spray
— And Svoboda is also the only antidepressant to ever receive breakthrough designation from the FDA, so great momentum and a long-term commitment to patients suffering with depression.